West Announces Quarterly Dividend and Share Repurchase Program

Core Viewpoint - West Pharmaceutical Services, Inc. has declared a quarterly dividend and announced a new share repurchase program, indicating a commitment to returning value to shareholders while maintaining financial flexibility [1]. Dividend Announcement - The Board of Directors declared a regular quarterly dividend of $0.22 per share on the Company's common stock, payable on May 6, 2026, to shareholders of record on April 29, 2026 [1]. Share Repurchase Program - A new share repurchase program has been authorized for the purchase of up to $1 billion of the Company's common stock, with the timing and number of shares to be repurchased dependent on stock price, economic conditions, and regulatory requirements [1]. - The previous share repurchase program was fully utilized before its expiration on December 31, 2025 [1]. Company Overview - West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services, supporting drug developers in the safe delivery of medicines [1]. - The Company generated $3.07 billion in net sales in fiscal year 2025 and operates over 50 sites, including 25 manufacturing facilities worldwide [1].